By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Actinium Pharmaceuticals, Inc. 

501 Fifth Avenue

New York City  New York  10017  U.S.A.
Phone: 646-459-4201 Fax: n/a


SEARCH JOBS








Company News
Actinium Pharmaceuticals, Inc. (ATNM.OB) To Present At The Canaccord Genuity 34th Annual Growth Conference On August 13th 8/5/2014 9:49:29 AM
Actinium Pharmaceuticals, Inc. (ATNM.OB) Provides Mid-Year Update Directed At Existing And Future Shareholders 8/4/2014 11:42:30 AM
Baylor Sammons Cancer Center Joins As Clinical Trial Site For Actinium Pharmaceuticals, Inc. (ATNM.OB)’s Actimab-A Clinical Trial 7/30/2014 9:56:29 AM
Actinium Pharmaceuticals, Inc. (ATNM.OB) Announces Launch Of Additional Antibody Actinium-225 Labeling Program 7/16/2014 9:36:35 AM
Actinium Pharmaceuticals, Inc. (ATNM.OB) Announces Exercise Of Greenshoe Option 7/11/2014 9:14:13 AM
Baylor Oncology Medical Director Joins Actinium Pharmaceuticals, Inc. (ATNM.OB)’s Iomab-B Scientific Advisory Board 7/8/2014 11:10:02 AM
Actinium Pharmaceuticals, Inc. (ATNM.OB) Joins Russell 3000®, Russell 2000®, Russell Global, and Russell Micro-Cap® Indexes 7/1/2014 11:21:21 AM
Actinium Pharmaceuticals, Inc. (ATNM.OB) Closes Public Offering Of Common Shares 6/30/2014 10:22:32 AM
Actinium Pharmaceuticals, Inc. (ATNM.OB) Announces Proposed Public Offering Of Common Shares 6/25/2014 11:42:40 AM
Actinium Pharmaceuticals, Inc. (ATNM.OB) Prices $12.5 Million Public Offering Of Common Shares 6/25/2014 8:59:42 AM
12345678910
//-->